New York, Sept. 27, 2023 (GLOBE NEWSWIRE) -- The global oligonucleotide API market size is projected to expand at ~ 10% CAGR between 2023 and 2035. The market is expected to garner a revenue of USD 5 ...
The Global Oligonucleotide (API) Industry is on the verge of a remarkable transformation, with a forecasted Compound Annual Growth Rate (CAGR) of 10.2% between 2022 and 2030. This substantial growth ...
(MENAFN- Meridian Market Consultants) The Reports and Insights, a leading market research company, has recently releases report titled “Oligonucleotide Active Pharmaceutical Ingredient (API) Market: ...
According to FMI – an ESOMAR-certified market research firm, the global oligonucleotide API market is estimated to reach US$ 3 Bn in 2020, and witness a CAGR of 11% through 2030. To Get a Sample Copy ...
A recent market study published by Future Market Insights (FMI) on the Oligonucleotide API market including global industry analysis for 2015-2019 & opportunity assessment for 2020-2030, delivers a ...
Nitto Denko Avecia, a CMO, said it will open its expanded oligonucleotide API manufacturing facility next month in Milford, Massachusetts. The maker of oligonucleotides, which are DNA or RNA molecules ...
NEWARK, Del., April 28, 2022 (GLOBE NEWSWIRE) -- According to FMI – an ESOMAR-certified market research firm, the global oligonucleotide API market is estimated to reach US$ 2.46 Bn in 2022, and ...
STA Pharmaceutical, the active pharmaceutical ingredient (API) manufacturing arm of WuXi AppTec, has opened a large-scale oligonucleotide API plant in Changzhou, China. The 2,800 m 2 facility is ...
SINGAPORE, Nov. 28, 2018 /PRNewswire/ -- ST Pharm Co Ltd was recognized with the Global API Manufacturing (Oligonucleotide) Growth Excellence Leadership award at the annual Frost & Sullivan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback